Based at Karolinska Institute Science Park, Stockholm Sweden
Scenario valuation of the shares in Auxesis Pharma Holding AB prior to the launch of the company’s analgesic product ASA.P is now available. One-Pager Scenario…
The shareholders in 559195-6486 Auxesis Pharma Holding AB, is hereby convened to the Annual General Meeting on June 10, 2022 at 15.00 in the conference…
Welcome as Board Members – Charlotta Larsson and Rune Nordström. Thank you to all shareholders for a great meeting and big thanks to Lars Larsson…
Scenario valuation of the shares in Auxesis Pharma Holding AB prior to the launch of the company’s analgesic product ASA.P is now available. One-Pager Scenario…
The shareholders in 559195-6486 Auxesis Pharma Holding AB, is hereby convened to the Annual General Meeting on June 10, 2022 at 15.00 in the conference…
Welcome as Board Members – Charlotta Larsson and Rune Nordström. Thank you to all shareholders for a great meeting and big thanks to Lars Larsson…
Om oss
Auxesis Pharma Holding AB, is a pharmaceutical company, based in Stockholm, Sweden. The team is interdisciplinary in the medical industry including a Certified Drug Consultant, Professor of Pharmacotherapy, Clinical Pharmacology and Sales and Marketing expertise. Auxesis Pharma Holding AB is a company that owns the rights of any additional and necessary patents in a specific medical research area.
Our product line
Our product line are designed for the global market. The company is working with the FDA for a second introduction to the US market, and are negotiating with strategic pharmaceutical companies for manufacturing and distribution. The active substances of our products has already been approved by the Medical Products Agency in Sweden, which will simplify the process for approval both domestically and globally.
Product in focus
ASA.P® is a non-perscription topical pain elimination drug that can be applied to the skin in different forms. The global challange today is quick pain relief for topical exposure and infections from sun burn, wasp/ mosquito bites, herpes, nettle, jelly fish etc. Our research reveals that it drastically deminishes pain caused by insect bites, poison plants, rashes, eczema, herpes etc in its own, unique way.
Investor hub
Auxesis Pharma Holding AB, is a pharmaceutical company, based in Stockholm, Sweden. The team is interdisciplinary in the medical industry including a Certified Drug Consultant, Professor of Pharmacotherapy, Clinical Pharmacology, and Sales and Marketing expertise.
Partners
+46 (0) 736 27 15 65
Copyright All rights reserved AUXESIS PHARMA HOLDING AB 2021